Showing results (571-580 of 580) with videos related to
Sort By:
Pageof 58
You have reached the last page of results.This site can display upto 580 results.
Frontiers in Chemistry|April 18, 2022
Research Advances on MatrineXiao-Ying Sun, Li-Yi Jia, Zheng Rong, et al.Nature Cell Biology|January 3, 2024
Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibitionWeiwei Cui, Meng Guo, Dong Liu, et al.International Journal of Surgery (London, England)|May 8, 2024
Endovascular treatment versus standard medical treatment in patients with established large infarct: a cohort studyChangwei Guo, Linyu Li, Jiandi Huang, et al.Thescientificworldjournal|October 24, 2015
Syndrome Differentiation Analysis on Mars500 Data of Traditional Chinese MedicineYong-Zhi Li, Guo-Zheng Li, Jian-Yi Gao, et al.Proceedings of the National Academy of Sciences of the United States of America|October 23, 2025
A PHF19-YTHDC1 condensate switches EZH2-mediated gene suppression to activation for prostate cancer progressionShuai Yuan, Dao-Jing Ming, Jiapeng He, et al.Science China. Life Sciences|June 25, 2019
Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young womenYue-Mei Hu, Meng Guo, Chang-Gui Li, et al.The New England Journal of Medicine|March 5, 2015
Long-term efficacy of a hepatitis E vaccineJun Zhang, Xue-Feng Zhang, Shou-Jie Huang, et al.The Lancet. Infectious Diseases|August 29, 2022
Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trialFang-Hui Zhao, Ting Wu, Yue-Mei Hu, et al.Journal of the National Cancer Institute|May 16, 2019
Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical TrialYou-Lin Qiao, Ting Wu, Rong-Cheng Li, et al.Imeta|October 20, 2025
Shaping the future of probiotics, live biotherapeutic products, and fecal microbiota transplantation: 30 scientific recommendations from the CHINAGUT ConferenceWeihong Wang, Nan Bu, Hailong Cao, et al.Pageof 58